Biotronik announced the highly-anticipated results of the Reform study. The study demonstrates that ICD (implantable cardioverter-defibrillator) patients with Biotronik's Home Monitoring can enjoy a reduction in follow-up visits by 58 percent. This in turn leads to patients reporting enhanced quality of life.
